FLOWERKIST SKIN CARE CSMT (FKST) Financials
Newest figures come from the 10-K for Q3 FY2022, filed Jan 13, 2023. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FKST SEC filings page.
This page shows FLOWERKIST SKIN CARE CSMT (FKST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Liability-heavy financing structure dominates the latest usable figures, with minimal reported assets and operating costs funded externally.
In FY2020, the net loss and operating cash flow were both-$5K , while financing cash flow provided$5K ; this near one-for-one pattern indicates reported activity was not internally funded.
The balance sheet showed limited asset backing:
Because revenue and gross-profit fields were absent in FY2020, the available records cannot establish operating scale or the economics of the underlying business.
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
FLOWERKIST SKIN CARE CSMT does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
FLOWERKIST SKIN CARE CSMT reported a net loss of $2K while operations used $2K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
FLOWERKIST SKIN CARE CSMT reported -$16K in net income in Q3 2022.
Not reported for Q3 2022.
Not reported for Q3 2022.
Not reported for Q3 2022.
Cash & Balance Sheet
Not reported for Q3 2022.
Not reported for Q3 2022.
Not reported for Q3 2022.
Margins & Returns
None of these metrics is reported for Q3 2022.
Capital Allocation
None of these metrics is reported for Q3 2022.
FKST Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
FKST Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2210-K | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q4'2010-K | Q3'2010-Q | Q3'1910-K | Q3'1810-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0 | $0 | $0 | $0 | $0 | N/A | $0 | $0 |
| Total Liabilities | $39K | $24K | $24K | $2K-63.1% | $5K | N/A | $878K0.0% | $878K0.0% |
| Current Liabilities | $39K | $24K | $24K | $2K-63.1% | $5K | N/A | $835K0.0% | $835K0.0% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | N/A | $43K0.0% | $43K0.0% |
| Total Equity | -$39K | -$24K | -$24K | -$2K+63.1% | -$5K | -$878K0.0% | -$878K0.0% | -$878K0.0% |
| Retained Earnings | -$3.4M | -$3.4M | -$3.4M | -$3.4M-0.1% | -$3.4M | N/A | -$1.8M0.0% | -$1.8M0.0% |
Not reported in any period shown, so not listed: Current Assets, Cash & Equivalents, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Long-Term Debt.
FKST Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
FKST Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Current Ratio, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$2K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where FLOWERKIST SKIN CARE CSMT Ranks
Frequently Asked Questions
Is FLOWERKIST SKIN CARE CSMT profitable?
No, FLOWERKIST SKIN CARE CSMT (FKST) reported a net income of -$2K in fiscal year 2021.
What is FLOWERKIST SKIN CARE CSMT's operating cash flow?
FLOWERKIST SKIN CARE CSMT (FKST) recorded an outflow of $2K in operating cash flow during fiscal year 2021, representing cash used by core business activities.
What are FLOWERKIST SKIN CARE CSMT's total assets?
FLOWERKIST SKIN CARE CSMT (FKST) had $0 in total assets as of fiscal year 2021, including both current and long-term assets.
Why is FLOWERKIST SKIN CARE CSMT's debt-to-equity ratio negative or not reported?
FLOWERKIST SKIN CARE CSMT (FKST) has negative shareholder equity of -$2K as of fiscal year 2021, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are FLOWERKIST SKIN CARE CSMT's earnings high quality?
FLOWERKIST SKIN CARE CSMT (FKST) reported a net loss of $2K while operations used $2K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.